Asia Fresh News

Asia Fresh Stories

Archive for May 2017

Asia’s Only Dedicated Innovation Summit Returning to Singapore

leave a comment »

-The only show in Asia dedicated purely to innovation as a practice is coming to Singapore on July 4 & 5.
SINGAPORE /PRNewswire/ — The Chief Innovation Officer Summit Singapore will bring together over 120 senior innovation leaders to discuss the practice of innovation in companies across the APAC region and globally.

Representatives from several companies will be discussing innovation across the two-day summit, with some of the organizations involved including AXA, Visa, Dyson, DBS Bank, and Nestle.

The summit will be focused on all elements of innovation, including implementation, empowerment, change management, and cultural change, amongst many others.

“Our aim since the summit was incepted has been to create a collaborative environment where innovation practices can be openly discussed” said summit director Ivy Chen. “I believe that we have been achieving this goal in every year and in every location, we have run the summit. The event in Singapore will be our best yet.”

Amongst those presenting at the summit will be Jim Roovers, Head of Electronics, R&D at Dyson. He will be discussing the story behind one of the world’s most innovative companies, how the 7 million pounds they spend weekly on R&D is used, and what the future of the company holds as they continue to move into other areas. “Having a problem-solving mindset to begin with is important in Dyson. The process of problem-solving can be further honed through hands-on experience developing Dyson products,” said Jim.

The summit will take place on July 4 & 5 at the Grand Copthorne Waterfront Hotel in Singapore.

For more information about the summit, please contact the events manager Ryan Yuan at or +852 5808 1636

About Innovation Enterprise

Innovation Enterprise Ltd, a division of Argyle Executive Forum, is a business-to-business media brand specializing in delivering the most innovative business solutions to executive-level decision makers. Innovation Enterprise produces a range on online and offline content, including, but not limited to, summits, online learning, webinars, and white papers, as well as offering other additional services such as lead generation and bespoke research.

Innovation Enterprise focuses on seven key channels – Finance, Supply Chain, Analytics, Big Data, Strategy, Digital, Innovation & Sports – to ensure that organizations are furnished with all the cutting-edge insights necessary to driving growth in the evolving business environment.

SOURCE Innovation Enterprise Ltd.

Source: Innovation Enterprise Ltd.

Written by asiafreshnews

May 25, 2017 at 5:40 pm

Posted in Uncategorized

A. O. Smith, The Water Council partner again to sponsor 2017 BREW Corporate technology challenge

leave a comment »

MILWAUKEE /PRNewswire/ — Once again this year, A. O. Smith Corporation and The Water Council are partnering to identify and support entrepreneurs and start-ups developing innovative freshwater technologies through a global technology challenge, BREW Corporate: Powered by A. O. Smith.

The challenge, which was announced this morning during the 2017 Water Leaders Summit in Milwaukee, will focus on three areas of interest to A. O. Smith:

Water treatment – High-efficiency water treatment technologies to remove contaminants such as trace heavy metals or microbiological materials from drinking water, as well as to improve water aesthetic characteristics including taste, odor and scale formation;
Water heating – High-efficiency, low-emission water heating technologies, most notably durable surface finish concepts, as well as components or systems that prolong the life of a water heater;
Sensors – Cost-effective sensor technologies for continuous or semi-continuous monitoring of trace level contaminants including heavy metals, bacteria and viruses, as well as other water quality indicators including hardness, total organic carbon and pH; and
IoT – Innovative technologies to sense and deliver information for residential and light commercial water applications as well as deliver extended battery life, reduced overall energy consumption, and predictive analytics. Security technologies to protect users’ privacy and manufacturers’ intellectual property.
To be considered, an entrepreneur or start-up must complete an online application that requests basic information about the business, the problem/issue being addressed, and details regarding the company’s stage of technology, core competencies and competitiveness. The deadline for entries is 11:59 p.m. CDT on June 30.

All entries will be reviewed by a panel of A. O. Smith personnel, The Water Council senior staff, and subject matter experts in the area of freshwater science. Recipients will be notified in July; the fall BREW Corporate (Business. Research. Entrepreneurship. In Wisconsin) program begins the week of Sept. 11. For a complete explanation of A. O. Smith’s target technologies, application criteria, and entry forms, go to

Recipients will receive a minimum investment of $50,000 from A. O. Smith as well as tuition to participate in The Water Council’s 12-month accelerator program in Milwaukee. In addition to the investment, the winning entrepreneurs receive:

A suite in the Global Water Center for up to 12 months;
Business model and operations training through The Water Council and University of Wisconsin-Whitewater Institute for Water Business;
Access to the Global Water Center’s Flow Lab and A. O. Smith product engineering labs;
Mentorship from A. O. Smith corporate development and senior engineering staff, as well as direct access to BREW Preferred Partners;
Attendance to conferences and pitch sessions with The Water Council; and
A one-year membership to The Water Council providing access to an extensive water technology network.
This is the second year A. O. Smith and The Water Council have sponsored BREW Corporate Technology Challenge. In 2016, A. O. Smith received approximately 20 proposals from water technology companies around the world.

About BREW Accelerator

BREW Accelerator, a program of The Water Council, is a world-class seed accelerator that unleashes water innovation by funding water technology startups from around the world with commercialization potential. The first-of-its-kind accelerator pairs a unique water-focused startup community with credible resources of the World Water Hub to help entrepreneurs accelerate results. Now in its fifth year, BREW has sponsored a total of 25 water technology companies. An expansion of the BREW Accelerator program, BREW Corporate partners with global corporations looking for new technologies to solve a specific challenge.

About A. O. Smith

A. O. Smith Corporation, with headquarters in Milwaukee, Wis., is a global leader applying innovative technology and energy-efficient solutions to products manufactured and marketed worldwide. The company is one of the world’s leading manufacturers of residential and commercial water heating equipment and boilers, as well as a leading manufacturer of water treatment products. For more information, visit

About The Water Council

The Water Council was established as a 501(c)(3) organization in 2009 by Milwaukee-area businesses, education and government leaders. With a mission of aligning the regional freshwater research community with water-related industries, the organization takes great pride in having created the leading water technology cluster in the United States and one of the most powerful in the world. Headquartered in the Global Water Center in Milwaukee, Wis., The Water Council links global water technology companies, innovative water entrepreneurs, government agencies, non-governmental organizations, acclaimed academic research programs and some of the nation’s brightest and most energetic water professionals. The driving force behind this success is the spirit of collaboration between public, private and academic sectors and the shared commitment to finding innovative solutions to critical global water issues.

SOURCE A. O. Smith Corporation

Source: A. O. Smith Corporation
Related Links:

Written by asiafreshnews

May 25, 2017 at 3:35 pm

Posted in Uncategorized

CLJI Worldwide Trial Enrolls First Patient in Clinical Study Evaluating the Performance of VIBLOK as a Barrier for Herpes Simplex Virus Transmission in Men and Women

leave a comment »

-CLJI Worldwide Sponsored Study Assessing the Safety and Performance of VIBLOK in HSV-2 infected adults as a barrier for virus transmission; Principal Investigators Named; First Patient Enrolled

BAY HARBOR ISLANDS, Florida /PRNewswire/ — CLJI Worldwide reports the start of the VIBLOK Safety And perFormancE Trial (SAFE Trial). The CLJI Worldwide SAFE Trial will evaluate the performance of VIBLOK for adults infected with herpes simplex virus-2 (HSV-2), the cause of genital herpes. VIBLOK is an investigational device developed to help reduce skin-to-skin HSV-2 transmission.

The global burden of HSV-2 is large, leaving over 400 million people living with the infection [1]. Genital lesions due to herpes are often very painful, can lead to substantial psychological morbidity, increase the risk of acquiring HIV [2-8], and can be transmitted from mother to infant during childbirth with potentially serious consequences [9, 10]. There is, however, no treatment eradicating the herpes simplex virus from the body, and disease management focuses on symptom relief, reducing recurrent episodes, and preventing viral transmission between sexual partners. Despite the use of medical treatments and condoms, genital herpes transmission may still occur through unprotected areas of the skin via micro-sized lesions, which are often exacerbated by grooming practices of the genital area, such as shaving and waxing [11].

VIBLOK is a virtually colorless, odorless, and tasteless cream designed to create a protective skin barrier that prevents the passage of viruses (e.g., HSV-2). Laboratory testing indicates that the cream can block virus passage at over 80% efficacy at the correct dosage. The SAFE Trial will provide an indication as to whether VIBLOK can safely and effectively block virus passage from the skin in HSV-2 infected people and in doing so, target the currently high prevalence of this sexually transmitted infection (STI) in industrialized and developing countries.

Dr. Annet Muetstege, PhD, is the clinical project manager, and the coordinating investigator for this clinical trial in The Netherlands is Dr. Vivienne van de Walle, M.D., PhD, CPI from PreCare Trial & Recruitment. The clinical trial strategy and protocol has been developed with help of the Study Steering Committee members Prof. Anna Wald, M.D., MPH at the University of Washington School of Medicine in Seattle, USA, Dr. Annemarie Wensing, M.D., PhD at the Utrecht University in Utrecht, The Netherlands, and Prof. Charles Boucher, M.D., PhD at the Erasmus University, Erasmus Medical Center in Rotterdam, The Netherlands. The prospective, non-randomized, comparative multi-center SAFE Trial is anticipated to last for 12 months in which up to 48 participants with HSV-2 will be enrolled and followed for one month. HSV will be measured from daily self-collected genital swabs before and after the application of VIBLOK.

The investigational centers will include six participating sites in The Netherlands and Germany. As a follow-up to the preclinical tests, this trial is designed to provide further supportive evidence for the efficacy of this skin barrier product to reduce the occurrence of HSV-2 transmission in a clinical setting. EB FlevoResearch in Almere, with Dr. Aletha Veenendaal as its principal investigator, enrolled the first trial participants at the beginning of April.

VIBLOK is an investigational device being evaluated in Europe and the outcomes of this clinical trial will be used to support the product application for CE Mark. It does not have an approved Investigational Device Exemption in the United States.

The clinical trial is being sponsored and managed by CLJI Worldwide which is committed to ’empowering people worldwide to make smart health decisions, and reducing global suffering by protecting them from the physical pain and emotional suffering of preventable diseases.’ CLJI Worldwide was established by Craig Lichtblau, M.D. and Jose Iparraguirre, M.D.; two practicing medical doctors in different specialties, who have been friends for over 30 years. They decided to combine their knowledge with that of a CEO and business leader in order to build an organization that strives to reduce pain and suffering in the world. The SAFE Trial reflects just one of the pioneering studies sponsored by CLJI Worldwide, that aims at investigating overlooked aspects of healthcare and subsequently solving real problems with scientifically and clinically proven products. “We are excited about the start of the SAFE Trial as it represents a significant milestone in our quest to revolutionize STI prevention and ultimately help millions of women and men across the globe live healthier, happier lives” says Ty Cross, President and Chief Executive Officer of CLJI Worldwide.


Looker KJ et al. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One. 2015 Jan 21;10(1):e114989. doi: 10.1371/journal.pone.0114989.
Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2002; 185: 45-52.
Strick LB, Wald A, Celum C. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons. Clin Infect Dis. 2006; 43: 347-56.
Celum C, Levine R, Weaver M, Wald A. Genital herpes and human immunodeficiency virus: double trouble. Bull World Health Organ. 2004; 82: 447-53.
Serwadda D, Gray RH, Sewankambo NK, Wabwire-Mangen F, Chen MZ, Quinn TC, et al. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. J Infect Dis. 2003; 188: 1492-7.
Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006; 20: 73-83.
Reynolds SJ, Quinn TC. Developments in STD/HIV interactions: the intertwining epidemics of HIV and HSV-2. Infect Dis Clin North Am 2005; 19: 415-25.
Reynolds SJ. The role of HSV-2 suppressive therapy for HIV prevention. Future Microbiol. 2009; 4: 1095–1097.
Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL, et al., et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997; 337: 509-15.
Brown Z. Preventing herpes simplex virus transmission to the neonate. Herpes2004; 11: 175A-86A.
Osterberg EC et al. Correlation between pubic hair grooming and STIs: results from a nationally representative probability sample. Sex Transm Infect 2016;0:1–5. doi:10.1136/sextrans-2016-052687


Source: CLJI Worldwide

Written by asiafreshnews

May 25, 2017 at 3:03 pm

Posted in Uncategorized

Early Response to Saxenda(R) Resulted in Weight Maintenance and Additional Weight Loss Over 56 Weeks

leave a comment »

PORTO, Portugal /PRNewswire/ —

Abstract# RS3:3

Today, results from a post hoc analysis of data from the SCALE Maintenance trial were presented at the 24th European Congress on Obesity (ECO) 2017. In the trial, adults who lost at least 5% of their initial weight during a low- calorie run-in period were randomised to receive Saxenda® (liraglutide 3 mg) or placebo. After 16 weeks of treatment with Saxenda®, participants who lost an additional 5% or more of their body weight (defined as ‘early responders’) were more likely to maintain weight loss and achieve greater additional weight loss over 56 weeks, compared with people losing less than 5% body weight after 16 weeks of Saxenda® treatment (‘early non-responders’).[1]

“In the obesity specialist setting, low-calorie diets combined with increased physical activity are commonly used to induce an initial weight loss in people with obesity. However, when the initial weight loss reaches a plateau and patients enter the ‘weight maintenance phase’ with less stringent caloric restriction, we often see that many experience weight regain,” said Dr Sean Wharton, medical director at the Wharton Medical Clinic, Ontario and SCALE clinical trial investigator. “As a consequence, pharmacotherapy can be used to help people with obesity in maintaining the weight loss that has already been achieved by a low-calorie diet and increased physical activity. These data are very encouraging to clinicians in this specialist setting, because they show that early responders to Saxenda® are able to both maintain and achieve additional weight loss.”

Of those who completed 56 weeks of treatment with Saxenda®, 68% were early responders to Saxenda® at week 16 and 32% were early non-responders. In addition to weight loss achieved during the run-in period, early responders experienced 9.9% weight loss, compared with 0.0% in early non-responders at 56 weeks.[1]

Following 56 weeks of treatment, 91.7% of early responders and 47.1% of early non-responders, had maintained or lost additional weight following the run-in period. No early responders regained their run-in weight loss over 56 weeks of treatment with Saxenda®, compared with 3.9% of early non-responders.[1]

There were similar incidences of total adverse events in early responders (92.7%) and early non-responders (91.0%). Gastrointestinal adverse events were more frequent in early responders compared with early non-responders (78.9% vs 62.7%).[1] Saxenda® was generally well-tolerated, with observed side effects in line with previous trials.[2]

About obesity

Obesity is a disease[3],[4] that requires long-term management. It is associated with many serious health consequences and decreased life expectancy.[5],[6] Obesity-related comorbidities include type 2 diabetes, heart disease, obstructive sleep apnoea (OSA) and certain types of cancer.[5],[7],[8] It is a complex and multi-factorial disease that is influenced by physiological, psychological, environmental, socio-economic and genetic factors.[9]

The global increase in the prevalence of obesity is a public health issue that has severe cost implications to healthcare systems. In 2014, 13% of adults, or approximately 600 million adults, were living with obesity.[10]

About Saxenda®

Saxenda® (liraglutide 3 mg) is a once-daily glucagon-like peptide-1 (GLP-1) analogue with 97% similarity to naturally occurring human GLP-1,[2] a hormone that is released in response to food intake.[11] Like human GLP-1, Saxenda® regulates appetite by increasing feelings of fullness and satiety, while lowering feelings of hunger and prospective food consumption, thereby leading to reduced food intake. As with other GLP-1 receptor agonists, Saxenda® stimulates insulin secretion and lowers glucagon secretion in a glucose-dependent manner.[2] Saxenda® was evaluated in the SCALE (Satiety and Clinical Adiposity – Liraglutide Evidence) phase 3a clinical trial programme.

In the EU, Saxenda® is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial BMI of ≥30 kg/m2 (obese), or ≥27 kg/m2 to <30 kg/m2 (overweight) in the presence of at least one weight-related comorbidity such as dysglycaemia (prediabetes or type 2 diabetes mellitus), hypertension, dyslipidaemia or obstructive sleep apnoea.[2]

Guidance is given in the label that treatment with Saxenda® should be discontinued after 12 weeks on the liraglutide 3.0 mg/day dose, if patients have not lost at least 5% of their initial body weight.[2]

About the SCALE Maintenance clinical trial

In the SCALE Maintenance clinical trial, adults with obesity (BMI ≥30 kg/m2) or who were overweight (BMI ≥27 kg/m2 to <30 kg/m2) with comorbidities (dyslipidaemia and/or hypertension), who lost at least 5% of their initial weight during a low-calorie diet (1200-1400 kcal/day) run-in period, were randomised to receive Saxenda® (n=212) or placebo (n=210) for 56 weeks, both as an adjunct to a reduced-calorie diet and increased physical activity.[1]

Novo Nordisk's phase 3 development programme, called SCALE, investigated liraglutide 3 mg for weight management. The SCALE clinical development programme consisted of four, placebo-controlled, multinational trials called: SCALE Obesity and Prediabetes, SCALE Diabetes, SCALE Sleep Apnoea and SCALE Maintenance.[12-16]

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 42,000 people in 77 countries and markets its products in more than 165 countries. For more information, visit, Facebook, Twitter, LinkedIn, YouTube


1. Wharton S, Jacobsen P, Arrone L. Early responders to liraglutide 3.0 mg as adjunct to diet and exercise from the SCALE Maintenance trial. Oral presentation number RS3:3. ECO. 2017.

2. EMA. Saxenda® (liraglutide 3 mg) summary of product characteristics. Available at: Last accessed: May 2017.

3. American Medical Association. A.M.A Adopts New Policies on Second Day of Voting at Annual Meeting. Obesity as a Disease. Available at: Last accessed: May 2017.

4. WHO. Obesity: Preventing and managing the global epidemic. Available at: Last accessed: May 2017.

5. Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009; 25:88.

6. Peeters A, Barendregt JJ, Willekens F, et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Annals of Internal Medicine. 2003; 138:24-32.

7. Gami AS, Caples SM, Somers VK. Obesity and obstructive sleep apnea. Endocrinology and Metabolism Clinics of North America. 2003; 32:869-894.

8. Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009; 373:1083-1096.

9. Wright SM, Aronne LJ. Causes of obesity. Abdominal Imaging. 2012; 37:730-732.

10. WHO. Obesity and Overweight Factsheet no. 311. Available at: Last accessed: May 2017.

11. Knudsen LB, Nielsen PF, Huusfeldt PO, et al. Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration. Journal of Medicinal Chemistry. 2000; 43:1664-1669.

12. Blackman A, Foster G, Zammit G, et al. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: The SCALE Sleep Apnea randomized clinical trial. International Journal of Obesity. 2016; 40:1310-1319.

13. Davies MJ, Bergenstal R, Bode B, et al. Efficacy of liraglutide for weight loss among patients with type 2 diabetes: The SCALE diabetes randomized clinical trial. Journal of the American Medical Association. 2015; 314:687-699.

14. Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015; 373:11-22.

15. le Roux C, Astrup A, Fujioka K, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. The Lancet. 2017; (published online Feb 22.)

16. Wadden TA, Hollander P, Klein S, et al. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study. International Journal of Obesity. 2013; 37:1443-1451.

Further information


Katrine Sperling

Åsa Josefsson


Peter Hugreffe Ankersen

Anders Mikkelsen

Hanna Ogren

Kasper Veje (US)

Source: Novo Nordisk

Written by asiafreshnews

May 19, 2017 at 4:23 pm

Posted in Uncategorized

European Paints and Coatings Market Advances with Emerging Digitization, Smart and Multifunctional Coatings Technologies

leave a comment »

End-user preferences and regulatory requirements drive new growth opportunities, finds Frost & Sullivan’s Visionary Science team

LONDON /PRNewswire/ — Growth in the European paints and coatings market continues to pick up pace. End-user preferences and regulatory requirements are shifting the market towards disruptive technologies such as Big Data and multifunctional/smart coatings, compelling coating companies to move beyond product manufacturing to become total solution providers.

“The development of smart/multifunctional coating systems and technologies, such as self-healing and anti-corrosion coatings are presenting tremendous growth and high-value opportunities for coating companies across specific industrial and infrastructural sectors like manufacturing and oil and gas,” said Visionary Science Industry Director, Dr Brian Balmer.

Trends in the European Paints and Coatings Market, Forecast to 2021, new analysis from Frost & Sullivan’s Future of Chemicals & Materials in Infrastructure & Mobility Growth Partnership Service programme, provides key drivers, restraints, technologies and growth opportunities across the European paints and coatings market with focus on architectural, automotive, protective and marine, powder coatings, and wood and furniture sectors.

For complimentary access to more information on this analysis, or to find out more, please email Evgenia Oleynikova, Corporate Communications:

From a regional perspective, end users in Western Europe demand high performance and sustainable solutions, while customers in the Eastern European countries are price-sensitive and prefer relatively standard and cheaper solutions.

Other trends and developments driving growth in the European paints and coatings market include:

Architectural coatings continue to be the biggest industry segment, with powder coatings as the fastest growing sub-segment due to the benefits it provides companies in terms of application costs, productivity, and reduced rejection rates.
Partnerships between original equipment manufacturers and insurance companies will boost opportunities in the European automotive coatings segment.
Better durability and versatility of polyurethane-dispersions (PUD) propel demand for indoor paints, wood flooring, exterior cladding, and roof coatings.
“The European paints and coatings market is still fragmented with a large number of regionally strong manufacturers,” noted Dr Balmer. “This provides an opportunity for larger participants to merge with, or acquire, regionally stronger players to expand customer base, build scale of operations, or acquire new technology solutions.”

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion

Trends in the European Paints and Coatings Market, Forecast to 2021

Evgenia Oleynikova
Corporate Communications — Europe
P: +48 224816210

Source: Frost & Sullivan
Related Links:

Written by asiafreshnews

May 19, 2017 at 4:16 pm

Posted in Uncategorized

Corona and Parley for the Oceans form a global partnership to address marine plastic pollution

leave a comment »

Commitment to protect 100 Islands against marine plastic pollution by 2020 and to turn them into symbols of change

Corona commits to the Parley AIR Strategy and adopts a plastic free philosophy across all aspects of the brand

TULUM, Mexico /PRNewswire/ — Today, on International Recycling Day, Corona and Parley for the Oceans announced their partnership in the movement to end marine plastic pollution, one of the biggest threats to human health and the survival of the planet’s largest and most important ecosystem — the world’s oceans. The long-term partnership launches with a plan to protect 100 Islands by 2020 starting in six key regions in different parts of the world – Mexico, Maldives, Australia, Chile, Italy and Dominican Republic.

Experience the interactive Multimedia News Release here:

An estimated 8 million metric tons of plastic waste enter the oceans each year. The problem is found in every known ecosystem and at every level of the food chain. If current marine pollution trends continue, the oceans will contain more plastic than fish by the year 2050. The partners will protect these regions by implementing Parley’s creative, multidisciplinary approach and signature formula, the Parley AIR Strategy (Avoid, Intercept, Redesign).

“We are all connected to the sea. The state of our islands is a powerful reminder of that fact. Plastic trash travels around the world and washes up on the most remote beaches, enclosing paradise with a belt of colorful plastic debris. It makes you understand that something is dead wrong. Plastic is a design failure. To raise awareness and immediately reduce the production of new plastic, we invented Ocean Plastic™ from upcycled marine debris and developed a formula for long-term change — the Parley AIR Strategy: Avoid plastic; Intercept plastic debris; Redesign materials, products and the ways we use them,” says Cyrill Gutsch, founder of Parley for the Oceans.

“In Corona, we found the perfect partner to bring this philosophy and strategy to a new territory: the beverage sector. Economy caused this plastic problem in the first place, but with the transformative power of collaboration and Eco Innovation, we can make it the key to the solution.”

Corona is a brand that was born at the beach, surrounded by ocean. It exists to inspire the world to disconnect from routine and reconnect with your essential nature. As a brand that celebrates a life lived outdoors and calls the beach and the oceans home, Corona is committed to protecting its homeland. But this home is facing a great danger.

For years, the brand has been engaging local communities to do beach cleanups with an initiative called ‘Save the Beach’ in several countries around the world. The partnership with Parley for the Oceans represents an evolution of Corona’s commitment to take care of the outdoors and the 100 islands represent the most iconic symbols of Corona’s paradise.

“We needed to take a stand and protect the heart and soul of our brand. We will spread our love for the oceans and make people understand that we need to take care of it, inspiring people to change their own behaviors. Corona is present in more than 180 countries and we have the opportunity and the responsibility to use that reach to be a voice for the oceans.” says Thiago Zanettini, Global Vice President of Corona.

Creating change
In addition to implementing Parley AIR, Corona and Parley are engaging like-minded ambassadors to represent the partnership in their countries. Chris Hemsworth (Australia), Diego Luna (Mexico), Ramon Navarro (Chile) and Nashla Bogaert (Dominican Republic) recently attended Parley Ocean School in the Maldives, an immersive experience bringing together a variety of different people in the ultimate classroom, the Indian Ocean.

Artists, designers, filmmakers, marine biologists, musicians, photographers and scientists explored the beauty of the oceans and witnessed the negative impact of plastic pollution on life underwater, on uninhabited islands and in local communities. The collective experience marks the starting point of an idea: Corona, Parley and a select group of creative change-makers will turn 100 islands into symbols of change.

“Participating in Parley Ocean School in the Maldives was an eye-opening experience,” said Diego Luna, actor and Corona x Parley ambassador. “When you picture beautiful islands and other beach destinations, you imagine them in their pristine state with clear blue waters, but then you see the problem up close and you realize that we are destroying paradise through our careless use of plastic. All of us can be part of the solution and help our beaches and oceans by taking simple actions to use less plastic in our daily lives, recycle more, and educate the people around us to do the same. I’m particularly proud to be affiliated with a program that is not only committed to protecting beaches around the world, but also in my homeland Mexico.

Chris Hemsworth added, “I’ve spent a large part of my life in and around the ocean, it’s where a lot of my happiest memories came from. If I had anxieties or worries, I’d head to the ocean and it was always the place where I could reset and be 100% present. My experience in the Maldives made it obvious how our short-term use of plastic has a long-term damaging effect on our oceans. I’m thrilled to be a part of this program, because I want to inspire people to find a solution and protect the world’s oceans so future generations can enjoy them like I do.”

Corona’s Commitment
Beyond protecting 100 Islands, Corona will implement a plastic conscious philosophy across all aspects of the brand by adopting the Parley AIR Strategy. The brand already avoids plastic by using wood across its promotional materials and serving ice cold Coronas in metal buckets all around the world.

This process will start with an assessment of the brand’s supply chain, leading to a long-term innovation pipeline to reduce and eventually replace plastic items that are currently in use. Additionally, there will be a focus on employee education and reduction of plastic use at all brand activations and events.

An immediate action is to a redesign one of the brand’s biggest global programs, Corona Sunsets – a series of festivals and events occurring worldwide – to not only align with the Parley AIR Strategy, but also to leverage the occasion as a means of educating more than 350,000 consumers a year.

For more information about the Corona and Parley partnership visit:



Parley for the Oceans

Helen Palmer

Tel: +442070670747


Silvia Raccagni

Tel: + 1 646 860 5906


Nicole Mayo

Michel Hakimian

Tel: +12124458393

Tel: + 33 12 59 41 93



Duncan Gordon,

Tel: +447795456999


About Corona
Born in Mexico, Corona is the leading beer brand in the country, the most popular Mexican beer worldwide exported to more than 180 countries. Corona Extra was first brewed in 1925 at the Cervecería Modelo in Mexico City and is still proudly produced entirely in Mexico.

Corona is a pioneer in the beer industry by being the first to use a transparent bottle showcasing its purity and high quality to the world. Each glass bottle is produced in a glass factory in Mexico owned by the brand. The artwork found on the bottle is hand painted, highlighting our commitment to quality in our packaging and our Mexican heritage.

No Corona is complete without the lime. Naturally adding character, flavor and refreshment, the lime ritual is an integral part of delivering an experience that is truly unique to Corona. The brand is synonymous with the beach and celebrates time outdoors. It invites people to pause, relax and enjoy the simple pleasures of life.

About Parley for the Oceans
Parley is the collaboration network where creators, thinkers and leaders come together to raise awareness for the beauty and fragility of our oceans and collaborate on strategies that can end their destruction. Headquartered in New York, Parley is known for renaming sustainability into ‘Eco Innovation,’ a concept realized through its high calibre collaborations and the introduction of Ocean Plastic™, a range of premium materials for the sports, fashion and luxury industries made from upcycled marine plastic debris.

Parley understands current plastic is a design failure, seeing the long-term solution for marine plastic pollution in the redesign of the harmful material. In the meantime, Parley created a catalyst innovation that provides an immediate replacement for new, virgin plastic: Ocean Plastic™. Together with its partners, in the last five years Parley raised awareness for the issue, boosted the general image of recycling and established the first global supply chain for marine plastic debris. Additionally, Parley created a funding mechanism that financially allows the implementation of the Parley AIR Strategy in four key areas: Communication and Education, Direct Impact, Research and Development, and Eco-Innovation.

*Parley AIR Strategy
The strategy is simple and easily scaled across private households, governments and corporations—and the creative industries that mold reality through ideas, materials and products. Based on the fact that at least every second breath we take is generated by the oceans, that mankind cannot survive on a planet with lifeless seas, the name Parley AIR also stands for three actions:

A = Avoid plastic.

“Avoid” includes initiatives to educate people on the importance of reducing plastic use, how to avoid unnecessary plastics and the value of replacing new, virgin plastic with Ocean Plastic™ materials made from upcycled marine debris. Through Parley Talks, ocean experts educate youth, creators, thinkers and leaders on the cause to inspire action. This education phase is the first step to ushering in change.

I = Intercept plastic waste.

“Intercept” is a comprehensive approach to collect existing waste using various methods from high seas to coastlines, divert plastics from landfill and prevent it from entering the oceans in the first place. While it is difficult and expensive to get plastic trash out of the open sea, where it is broken apart into tiny pieces and where only a small percentage is found at the surface, Parley is putting a strong focus on shorelines and beaches with its global network of partners and operations.

R = Redesign plastic materials and products.

“Redesign” addresses innovation around materials, products and new ways of using them. The original vision was to turn marine plastic debris into an opportunity and make it an attractive alternative to virgin plastic. With the name Ocean Plastic™. Parley successfully introduced this material to art, fashion and sports communities, setting a strong trend and new standard for the use of recycled materials. After establishing a global network with certified Parley Supply Chain partners comprised of recycling companies, yarn and fabric makers, Parley can now work towards its most challenging goal: the development of new materials that can replace plastic for good.

Source: Corona

Written by asiafreshnews

May 19, 2017 at 3:56 pm

Posted in Uncategorized

Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel

leave a comment »

SAN DIEGO /PRNewswire/ — ResMed today issued the following statement from David Pendarvis, the company’s global general counsel and chief administrative officer:

Experience the interactive Multimedia News Release here:

“ResMed filed a motion to dismiss the current International Trade Commission (ITC) complaint so that we can refile and incorporate additional evidence generated since the original complaint was filed. We believe this will make our strong case even stronger, and we remain confident in our position in the ITC. ResMed’s innovations have transformed the treatment of sleep-disordered breathing. We’re committed to protecting our innovation, which is why we’ve engaged in global legal proceedings with Fisher & Paykel.”

About ResMed
ResMed (NYSE: RMD) changes lives with award-winning medical devices and cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 3 million patients remotely monitored every day. Our 5,000-strong team is committed to creating the world’s best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 100 countries.­­ | Facebook | Twitter | LinkedIn

For media:

For investors:

Alison Graves

Agnes Lee



Logo –

Source: ResMed

Written by asiafreshnews

May 19, 2017 at 3:13 pm

Posted in Uncategorized

L’Oréal Paris Celebrates 20 Years of Cinema & Beauty in Cannes

leave a comment »

PARIS /PRNewswire/ —

As the 70th Cannes Film Festival opens, L’Oréal Paris marks its 20th year as official beauty partner.

L’Oréal Paris begins its festival-long celebration of beauty and cinema with the Cannes public, starting today on the L’Oréal Paris beach.

Marking its second decade as the Official Cannes beauty partner, today L’Oréal Paris inaugurates its free Outdoor Cinema open to the public to celebrate women in film with six of its ambassador actresses. The brand opens its Pop-up Boutique to all festival-goers; and gives the world the first red carpet beauty looks under the new creative direction of global makeup director Val Garland. This edition also welcomes the new L’Oréal Paris Global spokesperson, the young andaccomplished actress Elle Fanning, who makes her debut on the red carpet on May 17th.

As Cannes enters its second week, the brand celebrates 20 years of collaboration with the Cannes Film Festival, its Canniversary, with the L’Oréal Cinéma Club soirée.

Cannes 2017, it’s going to be a beauty!


May 17th -22nd Celebrating Beauty and Cinema: L’Oréal Paris Lights up the Big Screen with the L’Oréal Paris Outdoor Cinema open to the general public, Martinez beach.

From the opening night with Julianne Moore on the evening of May 17th, every evening has a different L’Oréal Paris actress. This includes new global ambassador Elle Fanning who will introduce her iconic film choices to the public, until May 22nd. These special free screenings start at 9pm every night.

May 17th Julianne Moore introduces Maps to the Stars, 2014, Award for Best Actress: 1h,52 minutes.
May 18th Susan Sarandon introduces Thelma and Louise, 1991, Out of Competition: 2h,10 minutes.
May 19th In her first role for the brand, Elle Fanning, new L’Oréal Paris actress ambassador, introduces Ginger & Rosa: 1h,30 minutes.
May 20th Aishwarya Rai introduces Devdas, 2002, Out of Competition: 3h,5 minutes.
May 21st Andie MacDowell presents Sex, Lies, and Videotape, 1989, Palme d’Or: 1h,40 minutes.
May 22nd Eva Longoria presents Lowriders, 2017, screening at the L’Oréal Paris Cinema following its worldwide release May 12th: 1h,39 minutes.

Democratizing the Festival experience to the public, the L’Oréal Paris Big Screen will show films at the same time as the official gala screenings, just along from the Palais des Festivals on the Martinez beach. Follow our social media channels to stay tuned for the latest updates.


The first immersive L’Oréal Paris Pop-up Boutique is now open! Open every day of the festival, 100% dedicated to makeup, festival-goers can discover the beauty influences and innovations in real-time. Including the new red carpet looks created by new global makeup director Val Garland, the maverick artist behind some of the most inventive looks in beauty today and at Cannes for the first time in her new role at L’Oréal Paris. Revolutionizing the shopping experience, shoppers can access free tutorials, expert advice and services with a chance to win the exclusive and elusive, Cannes red carpet tickets! The boutique will also give fans and consumers the opportunity to discover the latest collection of products, including the limited-edition Red Carpet Color Riche, featuring the Palme d’Or – a collector’s edition created for the brand’s Canniversary. There is also the opportunity to have red carpet looks recreated by our makeup artists and to meet our actress ambassadors’ in-store.


Two decades calls for a celebration! On May 24th, L’Oréal Paris throws its biggest Cannes party yet, with the greatest names in filmmaking and beauty in attendance. A night where cinema comes to life, and different scenography, projections and installations celebrate the art of filmmaking. This all comes together with a live showcase and exclusive performance, watched by every L’Oréal Paris actress in town. Guests will include Eva Longoria, Bianca Balti, Barbara Palvin, Doutzen Kroes, Lara Stone, Maria Borges, Irina Shayk, Kristina Bazan, Alexina Graham, Neelam Gill and Léna Meyer Landrut along with Marlon Teixeira; and fashions designer, Olivier Rousteing.


L’Oréal Paris hair and makeup artists bring beauty into the Golden Age of Hollywood by showcasing these styles on 40 top models including L’Oreal Paris ambassadors who will take to the charity runway at the Hotel du Cap-Eden Roc. This year’s list includes at the most sought-after faces on the Cannes schedule, including L’Oréal Paris ambassadors Doutzen Kroes, Bianca Balti, Barbara Palvin, Irina Shayk, Lara Stone, Maria Borges, Alexina Graham, Kristina Bazan, Neelam Gill and Marlon Teixeira among amfAR’s co-chairs. The event will bring together stars in film and fashion in an effort to raise awareness and funds in the fight against AIDS. The evening will be hosted by Eva Longoria and supported by the iconic fashion editor, Carine Roitfeld.


From the Opening to the Closing Ceremonies and every day in between, L’Oréal Paris reaffirms its commitment to diversity and to cinema by continuing to promote exceptional talent and women from all corners of the globe. On the red carpet for this historic edition of Cannes both Elle Fanning, the newly announced global face of L’Oréal Paris, Deepika Padukone, the Bollywood star, Guan Xiaotong, the 19-year-old Chinese acting sensation and Wotan Wilke Möhring, the German-born actor make their festival debut for L’Oréal Paris. Representing the brand to the international audience at Cannes and watching at home. The Angolan-born model, Maria Borges, will also represent the brand for the first time at this 70th edition.

Follow Cannes with us at:
TWITTER @lorealMakeup @lorealhair
SNAPCHAT @lorealMakeup @lorealhair
TWITTER @lorealparis
FACEBOOK LorealParisOfficial
YOUTUBE LorealParisOfficial
#lorealparis #lorealcannes #OfficialPartner #20years #Cannes2017

Source: L’Oréal Paris

Written by asiafreshnews

May 19, 2017 at 10:59 am

Posted in Uncategorized

ASEAN Ministers Convene at Sunway University to Drive Regional SDG Agenda

leave a comment »

KUALA LUMPUR, Malaysia/PRNewswire/ — In late April 2017, thought-leaders including Ministers, Former Ministers and representatives from government bodies and prominent economists specializing in sustainable development from the ASEAN region and Australia gathered at Sunway University in Sunway City, Malaysia. The gathering at a two-day ASEAN Ministers Workshop 2017 (AMW) was to share and improve their respective national strategies, and to formulate a regional mechanism to implement the United Nation’s Sustainable Development Goals (SDGs) in Southeast Asia.

Datuk Seri Abdul Rahman Dahlan, Minister in the Prime Minister’s Department, Malaysia (3rd from left) and Tan Sri Dr Jeffrey Cheah AO, Chancellor of Sunway University (2nd from right) with distinguished members from the first Plenary Discussion at the ASEAN Ministers Workshop
Datuk Seri Abdul Rahman Dahlan, Minister in the Prime Minister’s Department, Malaysia (3rd from left) and Tan Sri Dr Jeffrey Cheah AO, Chancellor of Sunway University (2nd from right) with distinguished members from the first Plenary Discussion at the ASEAN Ministers Workshop
Among the ASEAN Ministers who attended the first of its kind workshop were: Datuk Seri Abdul Rahman bin Dahlan, Minister in charge of the Economic Planning Unit, Malaysia; Dr Bambang Brodjonegoro, Minister of National Development Planning, Indonesia; and Saleumxay Kommasith, Minister of Foreign Affairs, Lao PDR.

Tan Sri Dr Ramon V Navaratnam, Pro Chancellor of Sunway University welcomed all the delegates to the workshop. In his welcome speech he emphasized on the important role corporates and SMEs play in supporting sustainable development, citing that it is in their best interest to support sustainable development as it will benefit their businesses in the future.

“This first AMW will be the catalyst of an annual high-level event for the ASEAN Ministers to meet, discuss and work towards achieving the SDGs for the region. The Jeffrey Sachs Center on Sustainable Development (JSC) is committed to support the UN’s blueprint for ending poverty in the world in the context of sustainable development and building a sustainable future for all,” said Professor Woo Wing Thye, Chair, AMW Organizing Committee.

With three plenary discussions focused on the ASEAN Experience, the Australian Experience and the Action Items for Southeast Asia, the workshop also included a public lecture by Professor Jeffrey Sachs, Chairman of JSC and a dialogue with the attending ASEAN ministers.

Taking a question from a member of the audience, Professor Jeffrey Sachs shared that universities have an important role to play in helping ASEAN countries attain the SDGs through higher education. From the development of deep excellence in science, technology, engineering and areas essential to supporting sustainable policy development, Professor Jeffrey Sachs urged universities to consider becoming incubators for SDG start-ups.

During the plenary discussion on Implementing SDGs: The ASEAN Experience, keynote speaker Datuk Seri Abdul bin Rahman Dahlan spoke of Malaysia’s commitment to adopting the 2030 Agenda on Sustainable Development via the Eleventh Malaysia Plan (2016 to 2020). Looking forward to getting everyone to work together to make the world a better place, Abdul Rahman shared the willingness of Malaysia to work with regional and international partners towards making the 17 SDG goals a reality.

Among those who participated in the workshop were Dato’ Dr Abdul Rashid Abdul Malik, CEO, Pulau Banding Foundation; Professor John Thwaites, Co-chair SDSN Leadership Council and Chair Monash Sustainable Development Institute, Australia; Professor Gamini Herath, Professor of Economics, School of Business, Monash University Malaysia; Professor Phouphet Kyophilavong, Vice-Dean of Economics, National University of Lao; Professor Sumiani Yusoff, Dean, Sustainability Science Research Cluster, Universiti Malaya; Professor Noraini Tamin, IPBES, Expert of Land Degradation and Restoration; Rosemarie G Edillon, Undersecretary of the National Development Office for Policy and Planning, National Economic and Development Authority, Philippines; Dr Somkiat Triratpan, Secretary to the Minister attached to the Prime Minister’s Office, Thailand; Philip Green, First Assistant Secretary, Southeast Asia Mainland and Regional Division, Department of Foreign Affairs and Trade, Australia; Professor Vu Quoc Huy, Director, Institute of Regional Sustainable Development, Vietnamese Academy of Social Sciences; and Professor Graeme Wilkinson, Vice-Chancellor of Sunway University.

The workshop was sponsored and organized by the Jeffrey Cheah Foundation (JCF); and co-organized by the Jeffrey Sachs Center on Sustainable Development (JSC), Jeffrey Cheah Institute on Southeast Asia (JCI), Pulau Banding Foundation, UKM’s Lestari and hosted by Sunway University.

About the Jeffrey Sachs Center on Sustainable Development

The Jeffrey Sachs Center on Sustainable Development (JSC) was established through a substantial gift from the Jeffrey Cheah Foundation to the United Nations Sustainable Development Solutions Network to support the global effort to achieve the 17 Sustainable Development Goals set by the United Nations in 2015. The Center is housed at Sunway University in Kuala Lumpur, Malaysia. Its vision is to embed sustainable development practices in everyday life. JSC will collaborate with government agencies, private sector groups, and civil society to formulate public policies and actions to realize the UN’s Sustainable Development Goals. It will serve as the Southeast Asia regional hub of the Sustainable Development Solutions Network to promote green development and social progress through research and education.

For further queries, kindly contact the Jeffrey Sachs Center on Sustainable Development at

Photo –

Source: Sunway University

Written by asiafreshnews

May 8, 2017 at 3:31 pm

Posted in Uncategorized

Frost & Sullivan Lauds Aprima’s Ambulatory Revenue Cycle Management Platform for Expanding Customers’ Margins through Superior Collection Efficiency

leave a comment »

-Aprima effectively caters to ambulatory practices that require error-free claims processing and timely alerts on key RCM issues
SANTA CLARA, Calif. /PRNewswire/ — Based on its recent analysis of the ambulatory revenue cycle management (RCM) market, Frost & Sullivan recognizes Aprima® Medical Software, Inc. with the 2017 United States Frost & Sullivan Award for Product Leadership. In response to the urgent need for a range of advanced IT solutions that can also generate more net patient revenue, Aprima rolled out a series of RCM solutions, such as patient access, clinical documentation, claims processing, denials management, and outcomes measurement, which cover the entire value chain. Aprima is the RCM vendor of choice for numerous independent and hospital-owned physician practices, serving 70 specialties and sub-specialties in the United States. It boasts an industry-leading client retention rate of 98% due to its dedication to providing best-in-class technologies and reliable customer support.

Frost & Sullivan recognizes Aprima® Medical Software, Inc. with the 2017 United States Product Leadership Award.
Frost & Sullivan recognizes Aprima® Medical Software, Inc. with the 2017 United States Product Leadership Award.
“Aprima’s flagship RCM platform combines sophisticated technology and proven billing expertise to help US ambulatory practices completely outsource their RCM departments,” said Frost & Sullivan Industry Analyst Koustav Chatterjee. “These practices rely on Aprima to optimize cost and collection through better eligibility checking, claims editing, and denial management.”

Aprima’s technology, coupled with advisory services, allows these practices to reduce average account receivable (A/R) durations, enhance corporate revenues, and optimize regulatory compliance with regard to:

ICD 10 transition
Integration of Centers for Medicare & Medicaid Services’ (CMS’) rules
Prepayment audits
Adherence to physician quality reporting system (PQRS) reporting objectives
Aprima consolidates the pricing for most RCM components and enhances customers’ margins on collection because they are not required to invest in multiple external RCM vendors. This lowers the operational expenditure on RCM design and deployment.

Many medical practices lack the time and expertise to manage appeals and other billing issues that can result in thousands of dollars lost every month. Aprima RCM provides that focus and expertise, partnering with each practice to help increase reimbursements, speed up payment time, and reduce denials and underpayments. Furthermore, the company’s account management team helps practices identify coding omissions, and compares payments to payer contracted allowables, in order to help prevent underpayments. The team also assesses denials and offers regulatory support. On average, Aprima RCM customers are paid significantly faster than other RCM services and industry benchmarks.

Aprima’s claims engine has more than 20 million edits and a 98% clean claims rate. Its customers prefer doing business with Aprima due to its deep customer centricity and demonstrable results. On average, physician practices that leverage the Aprima RCM platform improve collection efficiency by 7% to 9% and increase revenue up to 29%.

“Aprima has emerged as the ideal RCM solution for ambulatory providers that are replacing their incumbent electronic health record vendors and or RCM vendors due to their inability to optimally enable value-based care principles,” noted Koustav. “Overall, its top-class RCM platform, customer acquisition strategy for new accounts, and evidence-based product enhancements for existing accounts will ensure its continued success through 2020.”

Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality, gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About Aprima® Medical Software, Inc.

Aprima provides innovative electronic health record (EHR), practice management (PM), population health and revenue cycle management (RCM) solutions for medical practices. For nearly two decades, the company has delivered quality solutions that have helped tens of thousands of users enhance patient care and satisfaction, as well as improve their practices’ bottom lines. Its EHR/PM solution sets the benchmark for ease-of-use, speed and flexibility, thanks to its single application, single database and customizable design that adapts automatically to individual physician workflows. Aprima has a proven track record of compliance with government initiatives, such as Meaningful Use and ICD-10, and has been awarded pre-validation status for NCQA PCMH recognition. The company is based in Richardson, Texas and performs all development, support, implementation and RCM services from within the U.S. To learn more about how Aprima can help your practice, please visit, call us at 844 4APRIMA or email us at

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion.


Clarissa Castaneda
P: 210.477.8481
F: 210.348.1003

Joy Dinaro
Amendola Communications for Aprima
P: 847.809.0406

Photo –

Source: Frost & Sullivan
Related Links:

Written by asiafreshnews

May 8, 2017 at 3:05 pm

Posted in Uncategorized